Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000641313 | SCV000762954 | uncertain significance | Nemaline myopathy 2 | 2019-12-18 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 2883 of the NEB protein (p.Val2883Ile). The valine residue is moderately conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs369283016, ExAC 0.05%). This variant has not been reported in the literature in individuals with NEB-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000641313 | SCV001456993 | uncertain significance | Nemaline myopathy 2 | 2020-03-11 | no assertion criteria provided | clinical testing |